NSE · Healthcare · Drug Manufacturers - Specialty & Generic
| Document | Date |
|---|---|
| Investor presentation · Q1 FY27 ANUH PHARMA LIMITED – Q1 FY27 INVESTOR SUMMARY HEADLINE NUMBERS • Operating Revenue: Rs. 193.81 Cr, up 3.93% YoY (Q1 FY26: Rs. 186.48 Cr) • EBITDA: | 2026-08-19 |
| Quarterly results · Q1 FY27 ANUH PHARMA LTD. - Q1 FY2026-27 FINANCIAL SUMMARY HEADLINE NUMBERS • Revenue from operations (Q1 FY26-27): Rs 19,381.04 lakhs, down 4.1% from Rs 20, | 2026-08-07 |
| Annual report FY2026 | 2026-07-18 |
| Investor presentation · Q4 FY26 ANUH PHARMA LTD – INVESTOR SUMMARY FY2026 --- HEADLINE NUMBERS • Revenue FY26: Rs. 776 Cr. (+15.66% YoY vs Rs. 661.51 Cr. in FY25) • EBITDA FY26: R | 2026-05-28 |
| Quarterly results · Q4 FY26 ANUH PHARMA LTD. - FINANCIAL SUMMARY HEADLINE NUMBERS • FY 2025-26 Revenue from Operations: Rs. 77,165.74 lakhs (vs. Rs. 66,151.49 lakhs in FY 2024- | 2026-05-20 |
| Investor presentation ANUH PHARMA LIMITED – Q3 FY2026 INVESTOR SUMMARY HEADLINE NUMBERS • Q3 FY26 Revenue: ₹201 Cr (vs ₹186 Cr in Q2 FY26); +6.08% quarter-on-quarter grow | 2026-02-13 |
| Quarterly results · Q3 FY26 ANUH PHARMA LIMITED – FINANCIAL RESULTS SUMMARY Quarter & Nine Months Ended 31st December 2025 --- HEADLINE NUMBERS • Q3 FY2026 Revenue from Operat | 2026-02-06 |
| Investor presentation · Q2 FY26 ANUH PHARMA LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • H1 FY 2025-26 Revenue: INR 376.73 Cr (up 21.14% YoY from INR 310.98 Cr in H1 FY 2024-25) • | 2025-11-17 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹1.50 / share ex-date Aug 5, 2026 | 2026-08-05 |
| Dividend | ₹1.50 / share ex-date Aug 14, 2025 · record Aug 15, 2025 | 2025-08-14 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Anuh Pharma Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.